Literature DB >> 25324867

Neurofibromatosis type 1: a single center's experience in Korea.

Min Jeong Kim1, Chong Kun Cheon2.   

Abstract

PURPOSE: Neurofibromatosis 1 (NF1) is an autosomal dominant condition caused by an NF1 gene mutation. NF1 is also a multisystem disorder that primarily affects the skin and nervous system. The goal of this study was to delineate the phenotypic characterization and assess the NF1 mutational spectrum in patients with NF1.
METHODS: A total of 42 patients, 14 females and 28 males, were enrolled in this study. Clinical manifestations and results of the genetic study were retrospectively reviewed.
RESULTS: Age of the patients at the time of NF1 diagnosis was 15.8±14.6 years (range, 1-62 years). Twelve patients (28.6%) had a family history of NF1. Among the 42 patients, Café-au-lait spots were shown in 42 (100%), neurofibroma in 31 (73.8%), freckling in 22 (52.4%), and Lisch nodules in seven (16.7%). The most common abnormal finding in the brain was hamartoma (20%). Mental retardation was observed in five patients (11.9%), seizures in one patient (2.4%), and plexiform neurofibromas (PNFs) in four patients (9.5%). One patient with PNFs died due to a malignant peripheral nerve sheath tumor in the chest cavity. Genetic analysis of seven patients identified six single base substitutions (three missense and three nonsense) and one small deletion. Among these mutations, five (71.4%) were novel (two missense mutations: p.Leu1773Pro, p.His1170Leu; two nonsense mutations: p.Arg2517(*), p.Cys2371(*); one small deletion: p.Leu1944Phefs(*)6).
CONCLUSION: The clinical characteristics of 42 Korean patients with NF1 were extremely variable and the mutations of the NF1 gene were genetically heterogeneous with a high mutation-detection rate.

Entities:  

Keywords:  Clinical characteristics; Neurofibromatosis 1; Neurofibromatosis 1 genes

Year:  2014        PMID: 25324867      PMCID: PMC4198956          DOI: 10.3345/kjp.2014.57.9.410

Source DB:  PubMed          Journal:  Korean J Pediatr        ISSN: 1738-1061


  18 in total

1.  Identification of de novo deletions at the NF1 gene: no preferential paternal origin and phenotypic analysis of patients.

Authors:  M C Valero; I Pascual-Castroviejo; E Velasco; F Moreno; C Hernández-Chico
Journal:  Hum Genet       Date:  1997-06       Impact factor: 4.132

2.  TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP.

Authors:  Jayhong A Chong; Magdalene M Moran; Martin Teichmann; J Stefan Kaczmarek; Robert Roeder; David E Clapham
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 3.  [From gene to disease; neurofibromatosis type 1].

Authors:  A de Goede-Bolder; M H Cnossen; D Dooijes; A M van den Ouweland; M F Niermeijer
Journal:  Ned Tijdschr Geneeskd       Date:  2001-09-08

4.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

5.  Diffuse neurofibroma of scalp.

Authors:  A K Khan; S Deb; D K Ray; S N Mandal; S Mukhopadhaya; S Mandal
Journal:  Neurol India       Date:  2002-12       Impact factor: 2.117

Review 6.  Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.

Authors:  Stephen R Grobmyer; John D Reith; Amir Shahlaee; Charles H Bush; Steven N Hochwald
Journal:  J Surg Oncol       Date:  2008-03-15       Impact factor: 3.454

7.  Precise localization of NF1 to 17q11.2 by balanced translocation.

Authors:  D H Ledbetter; D C Rich; P O'Connell; M Leppert; J C Carey
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

Review 8.  Health supervision for children with neurofibromatosis.

Authors:  Joseph H Hersh
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

9.  Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.

Authors:  Jung Min Ko; Young Bae Sohn; Seon Yong Jeong; Hyon-Ju Kim; Ludwine M Messiaen
Journal:  Pediatr Neurol       Date:  2013-06       Impact factor: 3.372

Review 10.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

View more
  5 in total

1.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

2.  Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1.

Authors:  Mi-Ae Jang; Young-Eun Kim; Sun Kyung Kim; Myoung-Keun Lee; Jong-Won Kim; Chang-Seok Ki
Journal:  J Hum Genet       Date:  2016-04-14       Impact factor: 3.172

3.  Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1.

Authors:  Alessandro Stella; Patrizia Lastella; Daria Carmela Loconte; Nenad Bukvic; Dora Varvara; Margherita Patruno; Rosanna Bagnulo; Rosaura Lovaglio; Nicola Bartolomeo; Gabriella Serio; Nicoletta Resta
Journal:  Genes (Basel)       Date:  2018-04-17       Impact factor: 4.096

4.  Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1.

Authors:  Bin Mao; Siyu Chen; Xin Chen; Xiumei Yu; Xiaojia Zhai; Tao Yang; Lulu Li; Zheng Wang; Xiuli Zhao; Xue Zhang
Journal:  BMC Med Genet       Date:  2018-06-18       Impact factor: 2.103

5.  [Clinical aspects of Neurofibromatosis type 1 seen in the Department of Dermatology at University Hospital Antananarivo, Madagascar].

Authors:  Fandresena Arilala Sendrasoa; Aurélie Rasoarisata; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  Med Trop Sante Int       Date:  2022-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.